Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05997225 · ClinicalTrials.gov registry record · Phase 4
Tobacco Cessation at FDNY
A Phase 4 study, sponsored by Albert Einstein College of Medicine.
- Completed
- Registry status
- Phase 4
- Development phase
- 23
- Enrollment target
NCT05997225 is a Phase 4 study that has completed, run by Albert Einstein College of Medicine. The registered enrollment target is 23 participants.
The verdict
NCT05997225, a Phase 4 study, has completed, sponsored by Albert Einstein College of Medicine.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 23 participants
- Enrollment target
Study Summary
At the Fire Department of the City of New York (FDNY) World Trade Center Health Program, 36% of participants in the low dose computed tomography (LDCT) lung cancer screening program are current smokers, despite referral to the free FDNY Tobacco Cessation Program (Standard Care). Investigators propose testing an Enhanced Care program which includes opt-out enrollment; tobacco cessation counseling will be individually tailored to spirometry/LDCT results and treatment with varenicline starting 4 weeks prior to their target quit date. This randomized trial will compare enrollment and cessation outcomes in Standard Care vs. Enhanced Care groups of challenging-to-treat, high-risk smokers.
Interventions
- OTHER opt out enrollment, tailored counseling, varenicline started prior to target quit date
- OTHER opt in enrollment, non-tailored counseling, varenicline started prior to target quit date
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 23 participants |
| Start Date | 2024-05-31 |
| Est. Completion | 2025-10-13 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05997225
The ClinicalTrials.gov registry entry for NCT05997225 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 23 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Albert Einstein College of Medicine, which has 175 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which opt out enrollment, tailored counseling, varenicline started prior to target quit date is the first listed.
NCT05997225 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05997225 about?
NCT05997225 is a clinical study titled "Tobacco Cessation at FDNY". At the Fire Department of the City of New York (FDNY) World Trade Center Health Program, 36% of participants in the low dose computed tomography (LDCT) lung cancer screening program are current smokers, despite referral to the free FDNY Tobacco Cessation Program (Standard Care). Investigators propos...
What is the current status of trial NCT05997225?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 23 participants. The study started on 2024-05-31. Estimated completion is 2025-10-13.
What interventions are being tested in trial NCT05997225?
The interventions under investigation include: opt out enrollment, tailored counseling, varenicline started prior to target quit date (OTHER), opt in enrollment, non-tailored counseling, varenicline started prior to target quit date (OTHER).
Who is sponsoring clinical trial NCT05997225?
This trial is sponsored by Albert Einstein College of Medicine, which has 175 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.